Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C4H5NO4.Na.H.H2O |
| Molecular Weight | 173.0998 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H+].O.[Na+].N[C@@H](CC([O-])=O)C([O-])=O
InChI
InChIKey=PPTHNBYUFXSJPS-JIZZDEOASA-M
InChI=1S/C4H7NO4.Na.H2O/c5-2(4(8)9)1-3(6)7;;/h2H,1,5H2,(H,6,7)(H,8,9);;1H2/q;+1;/p-1/t2-;;/m0../s1
DescriptionSources: https://www.worldcat.org/title/fundamentals-of-biochemistry-life-at-the-molecular-level/oclc/910538334Advances in Protein Chemistry (1945), v.2, p.308, retrieved from: https://books.google.ru/books?id=QRyhIaEwrngCCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/15703381 |
https://www.ncbi.nlm.nih.gov/pubmed/3814227 |
https://www.ncbi.nlm.nih.gov/pubmed/16061593
Sources: https://www.worldcat.org/title/fundamentals-of-biochemistry-life-at-the-molecular-level/oclc/910538334Advances in Protein Chemistry (1945), v.2, p.308, retrieved from: https://books.google.ru/books?id=QRyhIaEwrngC
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/15703381 |
https://www.ncbi.nlm.nih.gov/pubmed/3814227 |
https://www.ncbi.nlm.nih.gov/pubmed/16061593
Disodium aspartate is used in organic biosynthesis.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q7L266 Gene ID: 80150.0 Gene Symbol: ASRGL1 Target Organism: Homo sapiens (Human) |
|||
Target ID: CHEMBL2094124 |
18.4 µM [EC50] | ||
Target ID: P08236 Gene ID: 2990.0 Gene Symbol: GUSB Target Organism: Homo sapiens (Human) |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: - |
no |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: - |
no | |||
| yes | ||||
| yes | ||||
| yes | ||||
Page: - |
yes | |||
Page: - |
yes |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Ketanserin for the treatment of preeclampsia. | 2001 |
|
| The biosynthesis of coenzyme A in bacteria. | 2001 |
|
| Metabolism of [1-(13)C)glucose and [2-(13)C]acetate in the hypoxic rat brain. | 2001 Apr |
|
| Selective cleavage of BLM, the bloom syndrome protein, during apoptotic cell death. | 2001 Apr 13 |
|
| Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies. | 2001 Feb |
|
| Aging-induced changes in 24-h rhythms of mitogenic responses, lymphocyte subset populations and neurotransmitter and amino acid content in rat submaxillary lymph nodes during Freund's adjuvant arthritis. | 2001 Feb |
|
| Protective effect of allopurinol on hepatic energy metabolism in ischemic and reperfused rat liver. | 2001 Feb |
|
| Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology. | 2001 Feb |
|
| Nicotinic receptors mediate the release of amino acid neurotransmitters in cultured cortical neurons. | 2001 Feb |
|
| Comparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C. | 2001 Feb |
|
| Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. | 2001 Feb |
|
| Endotoxin clearance and its relation to hepatic and renal disturbances in rats with liver cirrhosis. | 2001 Feb |
|
| Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS). | 2001 Feb |
|
| Serum hepatic biochemical activity in two populations of workers exposed to styrene. | 2001 Feb |
|
| Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen. | 2001 Feb |
|
| Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid-primed, nulliparous female rats. | 2001 Feb |
|
| Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. | 2001 Feb |
|
| Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat. | 2001 Feb 1 |
|
| Sodium nitroprusside-induced seizures and adenosine release in rat hippocampus. | 2001 Feb 16 |
|
| Changes in striatal electroencephalography and neurochemistry induced by kainic acid seizures are modified by dopamine receptor antagonists. | 2001 Feb 16 |
|
| Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. | 2001 Feb 16 |
|
| Evidence for microvesicular storage and release of glycine in rodent pinealocytes. | 2001 Feb 16 |
|
| A novel osteopontin-like protein is expressed in the trout ovary during ovulation. | 2001 Feb 2 |
|
| Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy. | 2001 Jan |
|
| Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. | 2001 Jan |
|
| Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial. | 2001 Jan |
|
| Characterization of peptide substrates and viral enzyme that affect the cleavage site specificity of the human spumaretrovirus proteinase. | 2001 Jan |
|
| Structure activity relationship of antiproliferative N-acyl-aspartic acid dimethyl ester. 2. Variation of the aspartyl moiety. | 2001 Jan |
|
| Relationship between crevicular aspartate aminotransferase levels and periodontal disease progression. | 2001 Jan |
|
| Dietary cancer risk from conditional cancerogens (tumor promoters) in produce of livestock fed on species of spurge (Euphorbiaceae). IV. Toxicologic and pathophysiologic observations in lactating goats and their suckling kids fed on the irritant herbs Euphorbia nubica and Euphorbia helioscopia: an etiologic model for investigations on the putative risk of cancer by consumption of food p. | 2001 Jan |
|
| Exercise improved accumulation of visceral fat and simultaneously impaired endothelium-dependent relaxation in old rats. | 2001 Jan |
|
| Chloroplast genetic engineering. | 2001 Jan |
|
| The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model. | 2001 Jan |
|
| Oxygen free radical generation in healthy blood donors and cardiac patients: the protective effect of allopurinol. | 2001 Jan |
|
| Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity. | 2001 Jan |
|
| Ehlers-Danlos syndrome type IV with a unique point mutation in COL3A1 and familial phenotype of myocardial infarction without organic coronary stenosis. | 2001 Jan |
|
| Effects of aflatoxin and carotenoids on growth performance and immune response in mule ducklings. | 2001 Jan |
|
| Lactococcus lactis LM0230 contains a single aminotransferase involved in aspartate biosynthesis, which is essential for growth in milk. | 2001 Jan |
|
| A comparison of the effect of nitroparacetamol and paracetamol on liver injury. | 2001 Jan |
|
| Propylene glycol toxicosis in a llama. | 2001 Jan 15 |
|
| Three-dimensional structure of Erwinia chrysanthemi pectin methylesterase reveals a novel esterase active site. | 2001 Jan 26 |
|
| Simplified technique of orthotopic liver transplantation in pigs. | 2001 Jan 27 |
|
| Positive and negative strands of HCV-RNA in sera and peripheral blood mononuclear cells of chronically hemodialyzed patients. | 2001 Jan-Feb |
|
| Characterization, amino acid sequence and evolution of edema-inducing, basic phospholipase A2 from Trimeresurus flavoviridis venom. | 2001 Jul |
|
| The effect of repeated gavage doses of fumonisin B1 on the sphinganine and sphingosine levels in vervet monkeys. | 2001 Jul |
|
| Serum hyaluronic acid as an early prognostic marker in biliary atresia. | 2001 Mar |
|
| Metabolic changes after cardiac surgery. | 2001 Mar |
|
| Stress responses and changes in protein metabolism in carp Cyprinus carpio during cadmium exposure. | 2001 Mar |
|
| In vivo evidence for accelerated generation of hydroxyl radicals in liver of Long-Evans Cinnamon (LEC) rats with acute hepatitis. | 2001 Mar 1 |
|
| Site-directed mutations in the mitochondrially encoded subunits I and III of yeast cytochrome oxidase. | 2001 Mar 1 |
Sample Use Guides
Aspartic acid is a nutrient component found in animal and vegetable sources. In clinical trials to alleviate opioid abstinence it was administered orally.
Route of Administration:
Oral
Activation of recombinant NMDA receptors was measured using two-electrode voltage clamp. Current and voltage electrodes were made from thin-walled borosilicate glass using a PP-830 electrode puller and when filled with 3 M KCl, possessed resistances of between 0.5 and 1.5 MΩ. Oocytes were voltage-clamped at potentials of -40 mV. Aspartate was able to activate wild type NR1/NR2A NMDA receptors with EC50 of 18.4 uM.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
323194-76-9
Created by
admin on Fri Dec 15 15:17:19 GMT 2023 , Edited by admin on Fri Dec 15 15:17:19 GMT 2023
|
PRIMARY | |||
|
DTXSID60186056
Created by
admin on Fri Dec 15 15:17:19 GMT 2023 , Edited by admin on Fri Dec 15 15:17:19 GMT 2023
|
PRIMARY | |||
|
4685ARH0AF
Created by
admin on Fri Dec 15 15:17:19 GMT 2023 , Edited by admin on Fri Dec 15 15:17:19 GMT 2023
|
PRIMARY | |||
|
23679051
Created by
admin on Fri Dec 15 15:17:19 GMT 2023 , Edited by admin on Fri Dec 15 15:17:19 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
